Skip to main content
Premium Trial:

Request an Annual Quote

NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date

NEW YORK – NantHealth said Wednesday that it has reached agreements for $137.5 million in new financing that will extend the maturity date of existing debt instruments to 2026. The transaction will close no later than April 27.

Under the deal, El Segundo, California-based NantHealth is issuing new senior unsecured convertible notes with a 2026 maturity to existing investors Highbridge Capital Management and Nant Capital. The latter is an investment vehicle of NantHealth's founder and CEO, Patrick Soon-Shiong, who is also the firm's largest shareholder.

The firm plans to use the proceeds of the new 2026 notes to retire existing convertible notes that are due in December, as well as for operating capital.

The 2026 notes will carry an interest rate of 4.5 percent, payable semiannually, though NantHealth said that investors will be able to convert the instruments to company stock. Terms will be disclosed in a future filing with the US Securities and Exchange Commission.

Additionally, Highbridge and Cambridge Equities — another Soon-Shiong company — have each agreed to convert $5 million of their investments in the 2021 notes into NantHealth common stock as of Wednesday. The stock closed Tuesday at $2.96 per share.

"Not only does this financing address the upcoming maturity of our 2021 notes, but importantly provides us with the resources to invest in our established businesses, NaviNet and Eviti, and accelerate the expansion of our recently acquired OpenNMS business," NantHealth Chief Operating Officer Ron Louks said in a statement.

"Last year, NantHealth made a strategic decision to expand beyond healthcare by providing enterprise solutions to help businesses in other industries," said Jonathan Segal, co-chief investment officer of Highbridge, referring to the July 2020 acquisition of OpenNMS Group, an open-source network management company. "We believe this financing will help NantHealth achieve this goal and continue further product expansion."

NantHealth has not drawn on a $100 million line of credit offered by Nant Capital in 2018. The firm has reported just one profitable quarter in its history, the first quarter of 2020.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.